We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

139 hedge funds and large institutions have $885M invested in Radius Health, Inc. in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 28

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

34% more call options, than puts

Call options by funds: $11.8M | Put options by funds: $8.82M

5% more funds holding

Funds holding: 133139 (+6)

44% less capital invested

Capital invested by funds: $1.57B → $885M (-$682M)

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
139
Holders Change
+6
Holders Change %
+4.51%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
24
Increased
56
Reduced
28
Closed
17
Calls
$11.8M
Puts
$8.82M
Net Calls
+$2.99M
Net Calls Change
-$6.46M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$406K
AG
77
Algert Global
California
$401K +$510K +22,533 New
DMK
78
David M. Knott
$392K +$498K +22,000 New
DCM
79
DAFNA Capital Management
California
$365K +$238K +10,500 +105%
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
$363K -$2.61M -115,535 -85%
WMSA
81
Weiss Multi-Strategy Advisers
New York
$358K +$2.17K +96 +0.5%
UBS AM
82
UBS AM
Illinois
$347K
WAM
83
Weiss Asset Management
Massachusetts
$337K +$140K +6,200 +49%
JG
84
Jefferies Group
New York
$318K +$405K +17,883 New
MIM
85
MetLife Investment Management
New Jersey
$313K
ARTA
86
A.R.T. Advisors
New York
$311K -$699K -30,900 -64%
NIT
87
NumerixS Investment Technologies
British Columbia, Canada
$310K +$267K +11,780 +210%
Wolverine Trading
88
Wolverine Trading
Illinois
$302K +$197K +8,710 +106%
VOYA Investment Management
89
VOYA Investment Management
Georgia
$295K -$16.2M -715,252 -98%
Invesco
90
Invesco
Georgia
$292K +$51.3K +2,267 +16%
PPA
91
Parametric Portfolio Associates
Washington
$285K -$27.8K -1,229 -7%
Legal & General Group
92
Legal & General Group
United Kingdom
$280K +$9.86K +436 +3%
OTC
93
Opera Trading Capital
France
$275K +$350K +15,459 New
DTL
94
Dynamic Technology Lab
Singapore
$264K +$336K +14,838 New
IBT
95
International Biotechnology Trust
United Kingdom
$257K
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$225K
SSA
97
Schonfeld Strategic Advisors
New York
$216K +$274K +12,100 New
Verition Fund Management
98
Verition Fund Management
Connecticut
$208K +$264K +11,679 New
Pacer Advisors
99
Pacer Advisors
Pennsylvania
$186K +$236K +10,434 New
SM
100
Salzhauer Michael
$134K

RDUS Hedge Fund Activity: Q3 2018 in Review

139 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q3 2018, worth a combined $885M — down 44% from $1.57B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new RDUS positions and 17 closed out — a net gain of 7 holders — while 56 added to existing stakes and 28 trimmed.

The largest buyer was Millennium Management, adding an estimated $38.3M. The largest seller was MPM Asset Management, exiting entirely with an estimated $118M sold.

  • 139 institutional investors held Radius Health, Inc. (RDUS) as of Q3 2018, up from 133 in Q2 2018.
  • Funds reported $885M of Radius Health, Inc. stock for Q3 2018, down 44% quarter-over-quarter.
  • 24 funds opened new Radius Health, Inc. positions in Q3 2018 and 17 closed out, a net change of +7 holders.
  • The largest Radius Health, Inc. buyer in Q3 2018 was Millennium Management, an estimated $38.3M added.
  • The largest Radius Health, Inc. seller in Q3 2018 was MPM Asset Management, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2018.